Clinical Trial of Photodynamic Therapy With Meso-Tetra (Hydroxyphenyl) Chlorin for Respiratory Papillomatosis | Zendy

Mark J. Shikowitz | Zendy; Allan L. Abramson | Zendy; Bettie M. Steinberg | Zendy; James A. DeVoti | Zendy; Vincent R. Bonagura | Zendy; Virginia Mullooly | Zendy; May Nouri | Zendy; A.M. Ronn | Zendy; Andrew Inglis | Zendy; John E. McClay | Zendy; Kathrine Freeman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Trial of Photodynamic Therapy With Meso-Tetra (Hydroxyphenyl) Chlorin for Respiratory Papillomatosis

Author(s) -

Mark J. Shikowitz,

Allan L. Abramson,

Bettie M. Steinberg,

James A. DeVoti,

Vincent R. Bonagura,

Virginia Mullooly,

May Nouri,

A.M. Ronn,

Andrew Inglis,

John E. McClay,

Kathrine Freeman

Publication year - 2005

Publication title -

archives of otolaryngology - head and neck surgery

Language(s) - English

Resource type - Journals

eISSN - 1538-361X

pISSN - 0886-4470

DOI - 10.1001/archotol.131.2.99

Subject(s) - medicine , photodynamic therapy , recurrent respiratory papillomatosis , photosensitizer , chlorin , gastroenterology , clinical trial , papilloma , larynx , disease , randomized controlled trial , surgery , pathology , chemistry , organic chemistry

To determine the efficacy of photodynamic therapy (PDT) with meso-tetra (hydroxyphenyl) chlorin (m-THPC) photosensitizer for recurrent respiratory papillomatosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research